Search Results 141-150 of 7603 for SIADH

  1. Publications - Anil Chauhan, M.B.B.S., M.D. - Mayo Clinic

    Gurudu R, Bansal D, Chauhan A, Tirumani SH. Tumor metrics imaging core labs: primer for radiologists. Abdom Radiol (NY). 2026 Sep; 51 (9):4725-4734 Epub ...

  2. Epilepsy - Doctors and departments - Mayo Clinic

    They include magnetic resonance imaging, subtraction ictal SPECT coregistered to MRI (SISCOM), electroencephalography, ketogenic diet, deep brain stimulation, ...

  3. A Phase 1 Dose Escalation And Cohort Expansion Study Of TSR-042, An Anti-PD-1 Monoclonal Antibody, In Patients With Advanced Solid Tumors - Mayo Clinic

    This is a multicenter, open-label, first-in-human Phase 1 study evaluating the anti programmed death receptor 1 (anti-PD-1) antibody TSR-042 in patients with ...

  4. Spontaneous coronary artery dissection (SCAD) - Doctors and departments - Mayo Clinic

    A torn blood vessel in the heart can cause a heart attack. Learn about the diagnosis and treatment of this medical emergency.

  5. https://www.mayoclinic.org/arabic_condition_consolidated_concepts.xml

  6. Publications - Shari L. Bornstein, M.D., M.P.H. - Mayo Clinic

    Andersen CA, Wieland ML, Bornstein SL, Huber JM, Sytsma TT, Bhuiyan MN, Wingo MT. Update in Outpatient General Internal Medicine: Practice-Changing Evidence ...

  7. Sarcoma - Doctors and departments - Mayo Clinic

    Learn about sarcoma, a rare cancer that forms in bone or soft tissue. Find out about sarcoma types, symptoms, causes, risk factors, diagnosis and treatment.

  8. Doctors and departments

    Barroso LF, et al. Clinical manifestations, diagnosis, and treatment of diphtheria. https://www.uptodate/com/search. Accessed Aug.19, 2021. Diphtheria. Merck ...

  9. Ivosidenib, Nivolumab, And Ipilimumab Combination In Previously Treated Subjects With Nonresectable Or Metastatic IDH1-Mutant Cholangiocarcinoma - Mayo Clinic

    Ivosidenib, Nivolumab, And Ipilimumab Combination In Previously Treated Subjects With Nonresectable Or Metastatic IDH1-Mutant Cholangiocarcinoma · Overview.

  10. Buparlisib in Treating Patients With Relapsed or Refractory Non-Hodgkin Lymphoma - Mayo Clinic

    This pilot clinical trial studies how well buparlisib works in treating patients with non-Hodgkin lymphoma that has returned or does not respond to treatment.